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Цель. оценить клиническую эффективность комбинированного метода лечения анального 
кондиломатоза, основанного на применении лазерной деструкции опухолей и иммуномодули-
рующей терапии.
Материал и методы. исследование реализовано в два этапа. в начале проведен ретроспек-
тивный сравнительный анализ результатов лечения 60 пациентов с использованием методов 
лазерной и электрохирургической деструкции анальных кондилом без иммуномодулирующей 
терапии. изучались длительность эпителизации ран, частота наступления рецидива. во втором, 
проспективном, исследовании у 60 пациентов физические методы деструкции кондилом допол-
нены терапией в виде человеческого рекомбинантного интерферона α2b и препарата имиквимод. 
Результаты. согласно полученным в ходе исследования данным, лазерная и электрохирурги-
ческая деструкция являются эффективными методами лечения аногенитального кондиломатоза. 
лазерная деструкция характеризовалась более ранней эпителизацией кожной раны (ANOVA, 
p=0,00001) и меньшим числом рецидивов заболевания в ближайшие два года наблюдения (Pear-
son's chisquare test, p=0,0270). при применении только методов физического воздействия отмечено 
значительно большее количество рецидивов в сравнении с комплексным подходом, при котором 
лазерная и электрохирургическая деструкция дополнены иммуномодулирующим и противовирус-
ным лечением в виде применения человеческого рекомбинантного интерферона α2b и препарата 
имиквимод (Cochran Q test, p = 0,022378). временной интервал без прогрессирования заболевания 
в группе пациентов с иммуномодулирующей терапией был значительно дольше, чем в других 
группах (Kaplan-Meier test, p=0,01528).
Заключение. результаты исследования позволяют утверждать, что использование лазерного 
излучения для деструкции анальных кондилом имеет ряд преимуществ перед электрокоагуляцией: 
более низкий риск развития рецидива, меньшие сроки наступления эпителизации раны. при-
менение иммуномодулирующей терапии в виде человеческого рекомбинантного интерферона 
α2b и местного использования препарата имиквимод эффективно дополняет физические методы 
деструкции кондилом, что позволяет достоверно снижать частоту рецидива заболевания.  
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Objective. To evaluate the clinical efficacy of the combined method of anal condylomatosis treat-
ment, based on laser tumor destruction and immunomodulatory therapy.
Methods. The study included 2 stages. At the first retrospective stage the analysis of 60 patients with 
anal condylomatosis treatment using laser and electrosurgical destruction methods was performed, im-
mune therapy was not used. The duration of the wound epithelialization, recurrence rate were studied. 
In the second, prospect study 60 patients were observed; the physical methods of condyloma destruction 
were supplemented with the therapy of human recombinant interferon α2b and imiquimod. 
Results. According to the data obtained during the study, laser and electrosurgical destruction are 
effective methods of anal condylomatosis treatment. Laser destruction has certain advantages: higher epi-
thelialization rate in the area of exposure (ANOVA, p=0.00001) and fewer recurrences of the disease in 
terms of 2 years’ follow-up (Pearson's chi-squared test, χ2=4.89; p=0.0270). The separate use of physical 
methods in the treatment of this pathology leads to a much greater number of relapses compared with 
the complex approach, where laser and electrocoagulation destruction is supplemented with immune and 
antiviral treatment by human recombinant interferon α2b and imiquimod (Cochran's Q test, Q=9.591549, 
p = 0.022378). Also the time interval without the disease progressing was longer in this groups (Kaplan-
Meier test, p=0.01528). 
Conclusions. The results of the study allow us to state that the use of laser radiation for the destruc-
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доказано, что использование лазерного излучения в качестве источника физической деструкции анальных 
кондилом имеет ряд преимуществ перед электрокоагуляционным воздействием. продемонстрировано, 
что применение человеческого рекомбинантного интерферона α2b и местное использование препарата 
имиквимод могут дополнять физический метод лазерной деструкции кондилом и позволяют снизить риск 
рецидива заболевания.
What this paper adds
It has been proved that the use of laser radiation as a source of physical destruction of anal condyloma has a number 
of advantages over electrocoagulation. It has been demonstrated that the use of human recombinant interferon α2b 
and topical use of imiquimod can supplement the physical method of laser destruction of genital condyloma and 
reduce the risk of recurrence of the disease.
tion of anal condylomas has several advantages over electrocoagulation: a lower risk of recurrence, a 
shorter period of epithelialization of the wound. The use of immunomodulatory therapy with human 
recombinant interferon α2b and topical application of imiquimod significantly reduces the frequency of 
the disease recurrence.
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Introduction
Anogenital condylomatosis is characterized by 
the appearance in a patient of benign tumorous 
formations in the region of the anus, perineum, 
genital organs caused mainly by 6 and 11 types 
of human papillomavirus (HPV) [1, 2]. The virus 
genome is a circular DNA molecule encoding 
two types of proteins: early proteins (E-proteins) 
that determine regulatory functions and virus 
multiplication, including oncogenic properties 
due to E6 and E7 proteins, and late proteins (L-
proteins) entering in the composition of the virion 
capsid. The virus attacks keratinocyte progenitor 
cells in the region of the basal membrane, the 
replication and release of viral particles occurs in 
keratinocytes that have reached the terminal stage 
of differentiation [3]. Therefore, the absence in a 
patient of exophytic neoplasms of papillomavirus 
origin does not indicate the elimination of the vi-
rus. The prevalence of anogenital condylomatosis 
reaches 22 cases per 100,000 population, with the 
average age of patients in economically developed 
countries ranging from 20 to 28 years [4, 5]. The 
high prevalence of the disease among the young 
working-age population of the developed countries 
determines the social and medical importance of 
pathology [6].
According to the classification by J. Handley 
and W. Dinsmoke (2001), several clinical forms 
are distinguished in case of affection with  human 
papillomavirus of the anogenital region [7]: 
– forms with clinical manifestations: warts 
(condyloma, flat warts, vulgar warts), intraepithelial 
neoplasia, dyskeratosis, in the absence of dysplasia 
(flat warts);
– forms with subclinical course: asymptomatic 
intraepithelial neoplasia, dyskeratosis in the absence 
of dysplasia (flat condylomas); 
– virus-carrying – hidden forms.
Subclinical forms are an asymptomatic lesion 
of the epithelium, which is determined only by 
molecular-biological methods of diagnosing the tis-
sue scarification. Patients’ diagnosis is made based 
on complaints and clinical examination data. To 
verify the virus in clinical practice, amplification 
methods of laboratory diagnostics are used more 
often, where the polymerase chain reaction is the 
most widespread and available method. 
For the removal of anogenital warts, the fol-
lowing methods are most often used in health care 
institutions of the Republic of Belarus: electrosur-
gical removal, laser destruction, cryodestruction, 
application of chemical compounds, mechanical 
excision of formations [8,9]. The rating of methods 
on the basis of popularity and frequency of use by 
physicians in outpatient practice in the Republic of 
Belarus is led by electrosurgical and laser destruction 
of genital warts. 
Using laser radiation to affect soft tissues of the 
perianal region and the genital area, according to 
various studies, in comparison with other sources of 
thermal exposure, permits to reduce energy penetra-
tion, which reduces undesirable damaging effects on 
deeper tissues and is characterized by a lower level 
of postoperative pain syndrome, edema, as well as 
a lower risk of postoperative complications [8, 10].
From the point of view of etiology and patho-
genesis of the disease, it is advisable to supplement 
the invasive methods of treatment with immu-
nomodulating and nonspecific antiviral therapy, 
which is reflected in some foreign reports and clini-
cal recommendations [11, 12]. Currently, a large 
number of immunocorrecting local and systemic 
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drugs have been developed. For the treatment of 
genital warts, the most promising direction is the 
use of human recombinant interferons [11] and 
imiquimod drugs [12,13]. Imiquimod is a deriva-
tive of imidazoquinolinamine. It is a modulator 
of an immune response that does not have direct 
antiviral or antiproliferative effects in vitro, but 
it stimulates the secretion of interferons, tumor 
necrosis factor and other cytokines. Interferons 
are naturally occurring proteins-messengers and 
have antiviral and antiproliferative activity. In 
the world practice, for the treatment of various 
diseases, three types of human interferons are cur-
rently used, however, for the treatment of genital 
warts in the perianal region, the most effective is 
the use of interferons №2b [11].
Objective. To evaluate the clinical efficacy 
of the combined method of anal condylomatosis 
treatment based on laser tumor destruction and 
immunomodulatory therapy.
Methods
The treatment results of 120 patients with 
anal condylomas in Minsk, Minsk and Vitebsk re-
gions for the period from 2012 to 2016 have been 
analyzed. It was revealed that in 98% of cases the 
doctors used electrocoagulation or laser destruc-
tion of neoplasms as the main and only method of 
treatment. To assess the effectiveness of this tactic, 
a two-stage study was performed in four clinical 
groups. 
At the first (retrospective) stage of the mul-
ticentre study, the therapy results of 60 patients 
with perianal condylomas being treated at 3rd City 
Clinical Hospital named after E.V. Klumov, 11th 
City Clinical Hospital, Vitebsk Regional Clinical 
Center, LLC "Medandrovit". The patients of the 
first group (group A, 30 people) underwent laser 
destruction, the patients of the second group (group 
B, 30 people) underwent electrosurgical destruc-
tion of the condyloma under local anesthesia. The 
inclusion criterion is the presence of perianal con-
dylomas in patients. Exclusion criteria: the previous 
stages of treatment for condylomatosis, as well as 
allergic reactions to local anesthetics, pregnancy, 
lactation and other standard contraindications for 
surgical intervention. The frequency and timing of 
the recurrence onset of the disease, the timing of 
epithelialization of burn skin wounds were analyzed.
In the second (prospective) study, 60 patients 
with condylomas of the perianal region participated, 
who were also divided into two groups by the meth-
od of simple randomization-assigning to each of 60 
patients a number that is a random number from 
the table of random numbers, and also by ranking 
these numbers in ascending order and according to 
the chosen treatment method: even numbers in the 
ranked row - group C, odd - group D.
Stratification for the duration of the disease 
or its severity has not been carried out. Criteria for 
inclusion and exclusion were the same as for patients 
in the first stage of the study. Patients of group C 
(30 people) underwent laser destruction of tumors, 
patients of group D (30 people) - electrosurgical 
destruction of condylomas. Interventions were 
performed under the local infiltration anesthesia. 
In all groups for laser destruction, radiation with 
a wavelength of 1.56 №m and a power of 10 W in 
continuous mode was used. For electrosurgical de-
struction, a high-frequency electrosurgical unit was 
used in the mode of monopolar coagulation with a 
power of 25 W. All surgical procedures performed 
in this study were outpatient and did not require 
hospitalization of patients.
Patients in groups C, D in the preoperative 
period were administered the recombinant human 
interferon №2b at a dose of 1,000,000 units rectally 
2 times a day for 10 days. Patients of Group C in 
the postoperative period were given imiquimod in 
the form of 5% cream topically after epithelializa-
tion of wounds 3 times a week for 4 weeks’ period.
Examinations of patients in the postoperative 
period were carried out at 3, 6, 12 and 24 months 
(control points).
Data on the age, field and duration of the 
disease of patients by groups are given in Table 
1. No statistically significant differences between 
groups A, B and also groups C, D were detected 
by these parameters (p>0.05).
Table 1
Separate statistical indicators in groups
Statistical indicators Group  A Group  B Group  с Group  D
Method of treatment Laser  
destruction






28.6±4.95 29.2±4.66 31.1±5.14 28.7±3.59
Sex ratio: M:W 2.32:1.00 1.72:1.00 2.00:1.00 2.75:1.00
Average duration of 
















The analysis of the obtained data was carried out 
on a personal computer using the package of licensed 
programs Statistica (version 6-Index, StatSoft Inc., 
USA, license number AXXR012E829129FA, 
serial number NXM12EU007224005571601) and 
Microsoft Excel 2010 (version 14.0.6129.5000, serial 
number 02278-001-0000106- 38272) for Windows 
XP. The hypothesis testing of the distribution 
normality of the investigated features was tested 
using the Shapiro-Wilk W test. Depending on the 
nature of the distribution, the descriptive statistics 
is represented by arithmetic mean and standard 
deviations for the normal distribution, and the median 
and quartiles for distributions that differ from the 
normal distribution. To analyze the conjugacy tables 
in independent groups, the Pearson's chi-square 
test was used, and the Cochran’s Q test was used 
for comparisons of multiple dependent groups. The 
statistical significance of the differences between the 
indices of normally distributed independent samples 
under the condition of multiple comparisons was 
estimated using the analysis of variance (ANOVA), 
in the absence of a normal distribution, the Kruskal-
Wallis test was used. In the presence of censored 
data, the Kaplan-Meier test was used.
Results
When analyzing the data obtained during the 
retrospective stage of the study, it was established 
that the progression of the disease after surgical 
treatment using "high energy" sources without con-
comitant immunocorrection was observed in 41% 
of cases. In group A, where the laser destruction 
of genital warts was performed, 10 cases (33%) of 
the disease progression were recorded during the 
two-year follow-up, which is significantly less than 
in group B (electrocoagulation), where 15 cases of 
disease progression (50%) were recorded (Pearson's 
chi-square test, p=0.0270).
During the second (prospective) part of the study, 
surgical treatment was supplemented with immuno-
modulatory therapy. As a result, during the two-year 
follow-up, the number of cases of the disease recurrence 
in patients of all groups was distributed as follows: in 
group A – 10 cases were recorded, group B – 15 cases, 
group C – 5 cases and group D – 13 cases. 
Thus, in a group where the laser destruction 
of condyloma was supplemented with immuno-
modulatory therapy (use of recombinant human 
interferon №2b and imiquimod-group C), there were 
significantly fewer relapses than in other groups 
(Cochran’s Q test, Q=9.591549, p = 0.022378).
In addition to the fact of disease progression, 
an important parameter of the effectiveness of treat-
ment is the length of the time interval between the 
completion of the therapy course and the moment 
of the recurrence onset. A comparison of the time 
parameters of the onset of recurrence or progression 
of the disease in patients of all four study groups 
revealed that during the two-year period in group C, 
where laser vaporization with immunomodulatory 
therapy was performed, the time interval without 
progression was significantly greater than in the oth-
er groups (Kaplan-Meier test, p=0.01528) (Fig. 1). 
A significant factor in determining the effective-
ness of treatment, affecting the clinical outcome and 
quality of patient’s life in the postoperative period, 
is the healing time of the postoperative wound. To 
estimate this index, the variance analysis (ANOVA) 
was used in patients of all groups (Fig. 2.)
From the data obtained from the analysis it 
follows that the epithelialization of the wounds 
occurred earlier in patients in those groups where 
the laser destruction of genital warts was performed 
(group A – 2.62 weeks, group C – 3.73 weeks) 
than in patients who underwent electrocoagulation 
of the genital warts (group B – 5.17 weeks, group 
D - 4.73 weeks). When comparing this indicator in 
a prospective study (in groups C and D), the dif-
ferences were significant (ANOVA, p = 0.00001).
Discussions
One of the most important indicators of mod-
ern methods of treatment, along with safety, is the 
low risk of recurrence or progression of the disease. 
The data obtained as a result of a retrospective study 
(rather high (41%) level of recurrence of clinical 
forms of anal condylomatosis after performing ther-
mal destruction of formations without the use of 
concomitant immune therapy) correspond to other 
known literature data and confirm the theory of the 
persistence of the virus, as well as probable difficul-
ties of complete damage to the tissues affected by 
the virus, as well as the presence of unrecognized 
(subclinical) forms of the disease [2, 4, 7, 8, 12].
Fig. 1. Time parameters of the recurrence onset and 
progression of the disease.
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The data obtained as a result of the second 
(prospective) part of the study indicate that in the 
group where the genital warts were supplemented 
with immunomodulatory therapy with preparations 
of recombinant human interferon №2b and imiqui-
mod, significantly fewer relapses were recorded.
The data obtained are also not unexpected, 
since the effectiveness of laser radiation, as well as 
the use of immune preparations for the treatment 
of anogenital warts, has been noted in numerous 
studies published earlier, and the use of a cream 
containing imiquimod is fully included in the stan-
dards of the European protocols for the treatment of 
diseases associated with the human papillomavirus 
, as well as sexually transmitted infections, imiqui-
mod was also approved by the American Medical 
Conciliation Conference on Infections, transmitted 
sexually in 2002 [2, 8, 10, 11, 13].
Since the comparison of the results obtained 
in the retrospective study cannot be regarded as 
reliable, it is incorrect to discuss the almost double 
advantage of laser destruction over the electrocoagu-
lation of genital warts as a result of the timing of the 
onset of epithelialization of the wound. However, 
significant differences in this indicator were noted 
in a prospective study.
Conclusions
The results of the research allow us stating that 
the use of laser radiation as a source of physical 
destruction of anal warts has several advantages 
over electrocoagulation: a lower risk of recurrence, 
a shorter period of epithelialization of the wound. 
However, the persistence of the virus, as well as 
the presence of subclinical forms of the disease 
requires the use of an integrated approach using 
immunomodulatory and antiviral therapy. The use 
of human recombinant interferon №2b and topical use 
of imiquimod may supplement the physical method 
of laser destruction of genital warts, which allows 
reducing the risk of the disease recurrence.
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